CA
COLL icon

Clearstead Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Clearstead Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$254 Buy
+7
New +$239 ﹤0.01% 3122
2025
Q4 		– Sell
-1
Closed -$35 – 2849
2025
Q3 		$35 Buy
+1
New +$35 ﹤0.01% 2998

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Clearstead Advisors's COLL Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 7 shares worth $254. The stake represents ﹤0.01% of the portfolio and ranks #3122 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in COLL as recently as Q3 2025.

Clearstead Advisors first reported a position in COLL in Q3 2025 and has held it in 2 quarters since. 101 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Clearstead Advisors held 7 shares of Collegium Pharmaceutical worth $254 as of Q2 2026.
  • Collegium Pharmaceutical was a new Clearstead Advisors position in Q2 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3122 holding.
  • Clearstead Advisors first reported a position in Collegium Pharmaceutical in Q3 2025 and has held it in 2 quarters since.
  • 101 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.